Q2 2025

Filed Jan 21, 2025 · 10-Q · 52 days after period end · 0001683168-25-000464

Q2 2025 · 10-Q

Revenue

$74.25K

+16.5% vs Q2 2024

Net Income

-$79.53K

N/M vs Q2 2024

EPS Diluted

-$0.00

N/M vs Q2 2024

Gross Profit$66,445+36.6%

Operating Income

Same quarter

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2012
Revenue	$74.25K	$63.75K	$82.58K	$15.52M
Net Income	-$79.53K	-$124.43K	-$219.89K	$1.81M
EPS Diluted	-$0.00	-$0.00	-$0.00	$0.13

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR